Literature DB >> 9581732

Increased oxidative stress in patients with congestive heart failure.

M Keith1, A Geranmayegan, M J Sole, R Kurian, A Robinson, A S Omran, K N Jeejeebhoy.   

Abstract

OBJECTIVES: We sought to study the markers of lipid peroxidation and defenses against oxidative stress in patients with varying degrees of heart failure.
BACKGROUND: Despite advances in other areas of cardiovascular disease, the morbidity and mortality from congestive heart failure (CHF) are increasing. Data mainly from animal models suggest that free radical injury may promote myocardial decompensation. However, there are no studies in humans correlating the severity of heart failure with increased free radical injury and antioxidants.
METHODS: Fifty-eight patients with CHF and 19 control subjects were studied. In addition to complete clinical and echocardiographic evaluations, the prognosis of these patients was established by measuring the levels of soluble tumor necrosis factor-alpha receptors 1 and 2 (sTNF-R1 and sTNF-R2). Oxidative stress was evaluated by measuring plasma lipid peroxides (LPO), malondialdehyde (MDA), glutathione peroxidase (GSHPx) and vitamin E and C levels.
RESULTS: The patients' age range, cause of heart failure and drug intake were comparable across the different classes of heart failure. Heart failure resulted in a significant increase in LPO (p < 0.005), MDA (p < 0.005), sTNF-R1 (p < 0.005) and sTNF-R2 (p < 0.005). There was a significant positive correlation between the clinical class of heart failure and LPO, MDA, sTNF-R1 and sTNF-R2 levels. There was an inverse correlation between GSHPx and LPO. With increased lipid peroxidation in patients with CHF, the levels of vitamin C decreased, but vitamin E levels were maintained.
CONCLUSIONS: These data demonstrate a progressive increase in free radical injury and encroachment on antioxidant reserves with the evolution of heart failure; they also suggest that oxidative stress may be an important determinant of prognosis. The therapeutic benefit of administering antioxidant supplements to patients with CHF should be evaluated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581732     DOI: 10.1016/s0735-1097(98)00101-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  113 in total

1.  Mechanical overload-induced apoptosis: a study in cultured neonatal ventricular myocytes and fibroblasts.

Authors:  Marion Persoon-Rothert; Karlien G C van der Wees; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  Myocardial infarction in mice alters sarcomeric function via post-translational protein modification.

Authors:  Benjamin S Avner; Krystyna M Shioura; Sarah B Scruggs; Milana Grachoff; David L Geenen; Donald L Helseth; Mariam Farjah; Paul H Goldspink; R John Solaro
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

3.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

Review 4.  Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart.

Authors:  Ethan J Anderson; Lalage A Katunga; Monte S Willis
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-02       Impact factor: 2.557

Review 5.  NO/redox disequilibrium in the failing heart and cardiovascular system.

Authors:  Joshua M Hare; Jonathan S Stamler
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 6.  Statin therapy in cardiovascular diseases other than atherosclerosis.

Authors:  Dominique Beaudry; Kenneth E Stone; Suzanne Wetherold; John Hemphill; Dat Do; John McClish; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

7.  Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress.

Authors:  Koji Otsuka; Fumio Terasaki; Hiroaki Shimomura; Bin Tsukada; Taiko Horii; Tadashi Isomura; Hisayoshi Suma; Yuro Shibayama; Yasushi Kitaura
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

Review 8.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

9.  Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice.

Authors:  Fuzhong Qin; Shannon Lennon-Edwards; Steve Lancel; Andreia Biolo; Deborah A Siwik; David R Pimentel; Gerald W Dorn; Y James Kang; Wilson S Colucci
Journal:  Circ Heart Fail       Date:  2009-12-16       Impact factor: 8.790

10.  Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons.

Authors:  Dongmei Liu; Lie Gao; Shyamal K Roy; Kurtis G Cornish; Irving H Zucker
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.